AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35321452 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group 1 (lesion tissue specimen)
Number of subjects: 100
Study 35321452 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly differentiated cancer foci
Number of subjects: 100
Study 35321452 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal liver tissue)
Number of subjects: 100
Study 35321452 — intervention group
Group type: COMPARATOR
Intervention: Observation group 2 (liver tissue around cancer lesion)
Number of subjects: 100
Study 33514591 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugira Muryango (SM)
Number of subjects: 1049
Study 33514591 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1049
Study 32242710 — intervention group
Group type: EXPERIMENTAL
Intervention: Resonantly driven singlet-triplet spin qubit
Number of subjects: 0
Study 32242710 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized benchmarking
Number of subjects: 0
Study 34780051 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise (PE) and nutritional guidance (NG)
Number of subjects: 94
Study 34780051 — intervention group
Group type: COMPARATOR
Intervention: Nutritional guidance (NG)
Number of subjects: 94
Study 33436925 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep apnea (SA) patients
Number of subjects: 102590
Study 33436925 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (matched by age and sex)
Number of subjects: 102590
Study 33151961 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaempferol
Number of subjects: 0
Study 33151961 — intervention group
Group type: COMPARATOR
Intervention: miR-21 inhibitor
Number of subjects: 0
Study 33151961 — intervention group
Group type: COMPARATOR
Intervention: Notch1 siRNA
Number of subjects: 0
Study 36451359 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft Touch Training (STT) - guided soft brushing of selected skin regions, 15-minute daily sessions for 4 weeks
Number of subjects: 57
Study 36451359 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR) - guided tensing and relaxing of selected muscle regions, 15-minute daily sessions for 4 weeks
Number of subjects: 57
Study 32248637 — intervention group
Group type: EXPERIMENTAL
Intervention: One-session exposure therapy
Number of subjects: 95
Study 32248637 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-session exposure therapy
Number of subjects: 95
Study 32248637 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (control)
Number of subjects: 95
Study 34605397 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural risk score model based on five variables: age > 75 years, serum creatinine level ≥ 1.5 mg/dL, diabetes mellitus, hypotension, acute myocardial infarction.
Number of subjects: 3469
Study 34605397 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 3469
Study 33561141 — intervention group
Group type: EXPERIMENTAL
Intervention: 50ml of 8.4% sodium bicarbonate (238 women)
Number of subjects: 477
Study 33561141 — intervention group
Group type: COMPARATOR
Intervention: 50 mL of 0.9% sodium chloride (239 women)
Number of subjects: 477
Study 32459919 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir for 5 days (200 mg on day 1, 100 mg once daily thereafter)
Number of subjects: 397
Study 32459919 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir for 10 days (200 mg on day 1, 100 mg once daily thereafter)
Number of subjects: 397
Study 32459919 — intervention group
Group type: COMPARATOR
Intervention: Remdesivir for 10 days
Number of subjects: 397
Study 36403889 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based survey (Group A)
Number of subjects: 59
Study 36403889 — intervention group
Group type: COMPARATOR
Intervention: Paper-based questionnaire (Group B)
Number of subjects: 59
Study 34639624 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention delivered by social insurance caseworkers
Number of subjects: 0
Study 34639624 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 0
Study 35133403 — intervention group
Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 46
Study 35133403 — intervention group
Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 46
Study 33529172 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad4-H5-Vtn
Number of subjects: 0
Study 32217112 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 136
Study 32217112 — intervention group
Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 136
Study 35819310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab combined with Bendamustine
Number of subjects: 0
Study 35819310 — intervention group
Group type: COMPARATOR
Intervention: Ofatumumab alone
Number of subjects: 0
Study 35819310 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine alone
Number of subjects: 0
Study 34256041 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET) for 16 weeks, performed twice weekly at low intensity
Number of subjects: 54
Study 34256041 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 54
Study 34256041 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET)
Number of subjects: 54
Study 616567519 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 100
Study 616567519 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100
Study 616567519 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 100
Study 616567519 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 100
Study 35271420 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric resistance exercise (RE)
Number of subjects: 14
Study 35271420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic resistance exercise (RE)
Number of subjects: 14
Study 35271420 — intervention group
Group type: COMPARATOR
Intervention: Comparison of isometric and dynamic RE
Number of subjects: 14
Study 32178953 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraluminal bronchial blocker (BB) for one-lung ventilation (OLV)
Number of subjects: 60
Study 32178953 — intervention group
Group type: COMPARATOR
Intervention: Single-lumen endobronchial tube for OLV
Number of subjects: 60
Study 32178953 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 34730769 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (200 mg twice daily)
Number of subjects: 335
Study 34730769 — intervention group
Group type: COMPARATOR
Intervention: Valsartan (160 mg twice daily)
Number of subjects: 335
Study 34730769 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 335
Study 34730769 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 335
Study 34730769 — intervention group
Group type: COMPARATOR
Intervention: Sacubitril/valsartan vs Valsartan
Number of subjects: 335
Study 34464397 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin
Number of subjects: 340
Study 34464397 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ?52 years
Number of subjects: 340
Study 34464397 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal age
Number of subjects: 340
Study 34464397 — intervention group
Group type: COMPARATOR
Intervention: Diabetes mellitus
Number of subjects: 340
Study 35458138 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous cinnamon extract (6 g/100 mL)
Number of subjects: 36
Study 35458138 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral glucose tolerance test only)
Number of subjects: 36
Study 33121544 — intervention group
Group type: EXPERIMENTAL
Intervention: Searching reputable websites for further information about the symptoms (n = 47)
Number of subjects: 127
Study 33121544 — intervention group
Group type: EXPERIMENTAL
Intervention: Free search of any websites for further information about the symptoms (n = 38)
Number of subjects: 127
Study 33121544 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 42)
Number of subjects: 127
Study 32565450 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one befriending by volunteers for people with ID (weekly visits for 6 months)
Number of subjects: 40
Study 35306266 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidance (human contact)
Number of subjects: 316
Study 35306266 — intervention group
Group type: COMPARATOR
Intervention: No guidance (control)
Number of subjects: 316
Study 35306266 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing module (without human contact)
Number of subjects: 316
Study 35306266 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated emails (without human contact)
Number of subjects: 316
Study 35306266 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic interview (human contact)
Number of subjects: 316
Study 33733588 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy after radical hysterectomy
Number of subjects: 367
Study 33733588 — intervention group
Group type: COMPARATOR
Intervention: Nonchemotherapy
Number of subjects: 367
Study 33733588 — intervention group
Group type: EXPERIMENTAL
Intervention: G3 patients
Number of subjects: 367
Study 35903950 — intervention group
Group type: EXPERIMENTAL
Intervention: l-arginine (8 grams)
Number of subjects: 10
Study 35903950 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn starch)
Number of subjects: 10
Study 32867605 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension-attributable out-of-pocket expenditure
Number of subjects: 410
Study 32867605 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct non-medical expenses
Number of subjects: 410
Study 32867605 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical out-of-pocket expenditure
Number of subjects: 410
Study 32867605 — intervention group
Group type: EXPERIMENTAL
Intervention: Catastrophic health expenditure
Number of subjects: 410
Study 34939313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoons group
Number of subjects: 164
Study 34939313 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaleidoscope group
Number of subjects: 164
Study 34939313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoons + Kaleidoscope group
Number of subjects: 164
Study 34939313 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study 32116261 — intervention group
Group type: EXPERIMENTAL
Intervention: FOG elicitation condition
Number of subjects: 130
Study 32116261 — intervention group
Group type: COMPARATOR
Intervention: Normal walking
Number of subjects: 130
Study 32116261 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking plus easy dual-tasks
Number of subjects: 130
Study 32116261 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking plus hard dual-tasks
Number of subjects: 130
Study 35319849 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 10%
Number of subjects: 120
Study 35319849 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 5%
Number of subjects: 120
Study 35319849 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 120
Study 32130359 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (administered orally for 7 days)
Number of subjects: 104
Study 32130359 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered orally for 7 days)
Number of subjects: 104
Study 616544310 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice Amplification (VA)
Number of subjects: 53
Study 616544310 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% NaCl Nebulization (NEB)
Number of subjects: 53
Study 32298225 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at ventilatory threshold 1 intensity (VT1)
Number of subjects: 17
Study 32298225 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 15% above VT1
Number of subjects: 17
Study 32298225 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 15% below VT1
Number of subjects: 17
Study 32298225 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at VT1
Number of subjects: 17
Study 33658996 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream
Number of subjects: 0
Study 34972214 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine plus durvalumab (Arm A)
Number of subjects: 84
Study 34972214 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine alone (Arm B)
Number of subjects: 84
Study 34826711 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention for psychosis (ICBTp), 8-week duration
Number of subjects: 100
Study 33753669 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.145% sodium fluoride gel in a custom tray during sleep
Number of subjects: 13
Study 35796575 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 132
Study 35796575 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 132
Study 32203138 — intervention group
Group type: EXPERIMENTAL
Intervention: Talacotuzumab plus decitabine
Number of subjects: 316
Study 32203138 — intervention group
Group type: COMPARATOR
Intervention: Decitabine alone
Number of subjects: 316
Study 35182288 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 0
Study 35182288 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc
Number of subjects: 0
Study 35182288 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline + Zinc
Number of subjects: 0
Study 35182288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33386662 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIg)
Number of subjects: 147
Study 33386662 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 147
Study 33386662 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological risk score
Number of subjects: 147
Study 33386662 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological score + predefined clinical score
Number of subjects: 147
Study 32386060 — intervention group
Group type: EXPERIMENTAL
Intervention: Crohn's disease
Number of subjects: 269
Study 32386060 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulcerative colitis/IBD unclassified
Number of subjects: 269
Study 34433769 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BuNa)
Number of subjects: 43
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiation therapy (TROG 01.04)
Number of subjects: 14170
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy omission (Dutch TME)
Number of subjects: 14170
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypofractionation (OCOG hypofractionation trial)
Number of subjects: 14170
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypofractionation (CHHiP)
Number of subjects: 14170
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive hypofractionation (FAST-Forward)
Number of subjects: 14170
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive hypofractionation (HYPO-RT-PC)
Number of subjects: 14170
Study 33779742 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated partial breast irradiation (NSABP B-39)
Number of subjects: 14170
Study 32692270 — intervention group
Group type: EXPERIMENTAL
Intervention: High NK cell count (≥184 × 10^6 cells/L) at baseline
Number of subjects: 72
Study 32692270 — intervention group
Group type: EXPERIMENTAL
Intervention: High NK cell count (≥184 × 10^6 cells/L) before cycle 2
Number of subjects: 72
Study 32692270 — intervention group
Group type: EXPERIMENTAL
Intervention: Low NK cell count and low NK activity at baseline (N=20)
Number of subjects: 72
Study 32692270 — intervention group
Group type: EXPERIMENTAL
Intervention: Low NK activity and low NK count at cycle 2 (N=18)
Number of subjects: 72
Study 35971654 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC)
Number of subjects: 498
Study 35971654 — intervention group
Group type: COMPARATOR
Intervention: Sham-RIC
Number of subjects: 498
Study 35971654 — intervention group
Group type: EXPERIMENTAL
Intervention: RIC
Number of subjects: 498
Study 35463135 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation (ER)
Number of subjects: 103
Study 35463135 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 103
Study 35889947 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut group (35 g of lightly salted dry-roasted peanuts prior to two main meals per day)
Number of subjects: 107
Study 35889947 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional low-fat weight loss diet)
Number of subjects: 107
Study 35889947 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut group
Number of subjects: 107
Study 33953312 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 161
Study 33953312 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 161
Study 33271639 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal attainment scaling (GAS) intervention provided by Dementia Support Practitioners (DSPs) including memory aids, training, and support
Number of subjects: 117
Study 33271639 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal attainment scaling (GAS) intervention
Number of subjects: 117
Study 33271639 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences of goal setting by DSPs
Number of subjects: 117
Study 32865422 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program group (17 nurses)
Number of subjects: 51
Study 32865422 — intervention group
Group type: COMPARATOR
Intervention: Knowledge-acquisition-only group (16 nurses)
Number of subjects: 51
Study 32865422 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (18 nurses)
Number of subjects: 51
Study 34535166 — intervention group
Group type: EXPERIMENTAL
Intervention: Running subcuticular suturing
Number of subjects: 142
Study 34535166 — intervention group
Group type: COMPARATOR
Intervention: Donati suturing
Number of subjects: 142
Study 35213496 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (NMB) with continuous infusion of rocuronium (0.5-1.0 mg kg⁻¹ h⁻¹)
Number of subjects: 181
Study 35213496 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (NMB)
Number of subjects: 181
Study 35213496 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular block (NMB) with continuous infusion of rocuronium (0.1-0.5 mg kg⁻¹ h⁻¹)
Number of subjects: 181
Study 35213496 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular block (NMB)
Number of subjects: 181
Study 35004776 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard immunosuppression plus metformin (500 mg twice daily)
Number of subjects: 105
Study 35004776 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard immunosuppression plus empagliflozin (25 mg once daily)
Number of subjects: 105
Study 35004776 — intervention group
Group type: COMPARATOR
Intervention: Standard triple immunosuppression alone
Number of subjects: 105
Study 35929983 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cryoneurolysis
Number of subjects: 60
Study 35929983 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 60
Study 32144074 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV-AS04 vaccine (4 doses of 20 mcg each by intramuscular route)
Number of subjects: 272
Study 32144074 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV-AS04 vaccine
Number of subjects: 272
Study 36245339 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-delivered medication review intervention
Number of subjects: 404
Study 36245339 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown bag review
Number of subjects: 404
Study 36245339 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient priority assessment
Number of subjects: 404
Study 36245339 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 404
Study 32791589 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with standardized dust mite vaccine for 2 years
Number of subjects: 40
Study 32791589 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo and conventional drug treatment)
Number of subjects: 40
Study 32279170 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy
Number of subjects: 3447
Study 32279170 — intervention group
Group type: COMPARATOR
Intervention: Open radical prostatectomy
Number of subjects: 3447
Study 32279170 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgical techniques
Number of subjects: 3447
Study 34294134 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-Hz electroacupuncture
Number of subjects: 120
Study 34294134 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-Hz electroacupuncture
Number of subjects: 120
Study 34294134 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-Hz electroacupuncture
Number of subjects: 120
Study 34294134 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 120
Study 34294134 — intervention group
Group type: EXPERIMENTAL
Intervention: Opposing needling
Number of subjects: 120
Study 34294134 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 120
Study 36199765 — intervention group
Group type: EXPERIMENTAL
Intervention: Small incision reduction and suture linked with functional appliance
Number of subjects: 90
Study 36199765 — intervention group
Group type: COMPARATOR
Intervention: Oral drug therapy and small incision reduction and suture
Number of subjects: 90
Study 32675472 — intervention group
Group type: EXPERIMENTAL
Intervention: SOX10 staining
Number of subjects: 26
Study 32675472 — intervention group
Group type: COMPARATOR
Intervention: H&E staining
Number of subjects: 26
Study 35867274 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin with trihexyphenidyl
Number of subjects: 60
Study 35867274 — intervention group
Group type: COMPARATOR
Intervention: Trihexyphenidyl alone
Number of subjects: 60
Study 33608728 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 60
Study 33608728 — intervention group
Group type: COMPARATOR
Intervention: Laser ablation (LA)
Number of subjects: 60